FDA Broadens COVID‑19 Vaccine Probe to Include Adult Fatalities

Agency’s earlier claim about ten child deaths remains unsubstantiated

The U.S. Food and Drug Administration announced Tuesday that its ongoing review of COVID‑19 vaccine safety will now encompass reported adult deaths potentially linked to the shots. This expansion follows an earlier statement in which the agency suggested that ten children had died in connection with the vaccines. However, the FDA has not released any data or documentation to substantiate those claims.

Public health officials emphasized that the investigation is part of a routine safety‑monitoring process and that no causal relationship has been established. The agency urged healthcare providers to continue reporting any adverse events through the Vaccine Adverse Event Reporting System (VAERS).

Critics argue that the lack of transparency hampers public trust, while the FDA maintains that it is committed to a thorough and evidence‑based assessment.